Carsten W. Lederer

Senior Scientist, Head, Blood Disorders Genetics and Thalassaemia Department,The Cyprus Institute of Neurology & Genetics

Dr Lederer is Associate Professor and program coordinator at the CING Postgraduate School, and executive board member of the National Committee for Thalassemia and Other Hemoglobinopathies, the Human Variome Project, and the European Paediatric Translational Research Infrastructure (EPTRI). His department performs (i) clinical hematology and population-wide diagnostic services as national molecular reference laboratory and as HCP under ERN EuroBloodNet, including carrier screening, prenatal diagnostics, PGT-M and NIPT, (ii) translational research for the discovery of biomarkers and disease modifiers, (iii) genome editing and advanced therapy development for rare blood disorders, and (iv) development and coordination of patient registries, databases and epidemiology resources, including the world-leading ITHANET Portal and the ClinGen-recognized Hemoglobinopathy Variant Curation Expert Panel.

Dear delegates,

In light of the latest developments and as a precautionary measure, the Cyprus Presidency of the Council of the EU 2026 has decided to postpone this week’s Presidency Conference Advancement of Treatments for Rare Diseases, scheduled to take place in Cyprus 5–6 March 2026.

Further information regarding possible re-arrangement and new dates will be communicated in due course.

We apologise for the inconvenience caused by these adjustments and thank you for your understanding.

Yours sincerely,
The Organizing Committee
Conference “Advancement of Treatments for Rare Diseases”
Cyprus Presidency of the Council of the European Union 2026